Dyne Therapeutics Inc (DYN) Insider Trading
- $43,295,935.73
- $760,677,573.77
- March 13, 2025
- Franklin Resources Inc
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 13, 2025 | Insider | 143 | $12.12 | Sell | $1,733.16 | |
March 11, 2025 | Insider | 2,153 | $11.38 | Sell | $24,501.14 | |
March 11, 2025 | SVP | 1,343 | $11.38 | Sell | $15,283.34 | |
Dec. 11, 2024 | SVP | 1,455 | $28.12 | Sell | $40,914.60 | |
Dec. 11, 2024 | Insider | 2,334 | $28.12 | Sell | $65,632.08 | |
Nov. 18, 2024 | Director | 16,500 | $28.73 | Sell | $474,045.00 | |
Nov. 14, 2024 | Director | 782 | $33.10 | Sell | $25,884.20 | |
Oct. 16, 2024 | Director | 23,671 | $35.35 | Sell | $836,769.85 | |
Sept. 25, 2024 | Director | 2,357 | $35.06 | Sell | $82,636.42 | |
Sept. 23, 2024 | Director | 40,831 | $35.32 | Sell | $1,442,150.92 | |
Sept. 20, 2024 | Director | 79,411 | $36.45 | Sell | $2,894,530.95 | |
Sept. 18, 2024 | Insider | 2,339 | $34.55 | Sell | $80,812.45 | |
Sept. 18, 2024 | SVP | 1,390 | $34.55 | Sell | $48,024.50 | |
Sept. 18, 2024 | COO | 8,976 | $34.41 | Sell | $308,864.16 | |
Sept. 4, 2024 | CEO | 32,000 | $33.04 | Buy | $1,057,280.00 | |
June 24, 2024 | COO | 10,163 | $35.33 | Sell | $359,058.79 | |
June 21, 2024 | COO | 29,787 | $35.01 | Sell | $1,042,842.87 | |
June 12, 2024 | COO | 40,000 | $33.36 | Sell | $1,334,400.00 | |
June 11, 2024 | Insider | 2,136 | $31.34 | Sell | $66,942.24 | |
June 10, 2024 | SVP | 1,590 | $30.23 | Sell | $48,065.70 | |
June 10, 2024 | COO | 80,000 | $30.24 | Sell | $2,419,200.00 | |
May 20, 2024 | Insider | 30,426 | $32.96 | Sell | $1,002,840.96 | |
May 16, 2024 | COO | 2,738 | $28.27 | Sell | $77,403.26 | |
May 16, 2024 | Insider | 2,705 | $28.27 | Sell | $76,470.35 | |
May 16, 2024 | SVP | 2,588 | $28.27 | Sell | $73,162.76 | |
March 11, 2024 | COO | 2,292 | $25.70 | Sell | $58,904.40 | |
March 11, 2024 | SVP | 2,672 | $25.28 | Sell | $67,548.16 | |
March 11, 2024 | CEO | 66,387 | $25.67 | Sell | $1,704,154.29 | |
March 11, 2024 | Insider | 1,585 | $25.70 | Sell | $40,734.50 | |
March 7, 2024 | COO | 1,591 | $25.85 | Sell | $41,127.35 | |
March 7, 2024 | SVP | 2,273 | $25.85 | Sell | $58,757.05 | |
March 7, 2024 | Insider | 2,373 | $25.85 | Sell | $61,342.05 | |
March 7, 2024 | CEO | 9,086 | $25.85 | Sell | $234,873.10 | |
Feb. 29, 2024 | SVP | 3,429 | $27.50 | Sell | $94,297.50 | |
Feb. 29, 2024 | CEO | 5,520 | $27.50 | Sell | $151,800.00 | |
Feb. 29, 2024 | Insider | 4,268 | $27.50 | Sell | $117,370.00 | |
Feb. 28, 2024 | Director | 190,920 | $24.84 | Sell | $4,742,452.80 | |
Feb. 28, 2024 | Major Shareholder | 154,674 | $24.84 | Sell | $3,842,102.16 | |
Feb. 26, 2024 | Major Shareholder | 201,095 | $23.72 | Sell | $4,769,973.40 | |
Feb. 26, 2024 | Director | 248,219 | $23.72 | Sell | $5,887,754.68 | |
Feb. 23, 2024 | Major Shareholder | 159,542 | $22.70 | Sell | $3,621,603.40 | |
Feb. 22, 2024 | Director | 119,360 | $22.66 | Sell | $2,704,697.60 | |
Feb. 21, 2024 | Major Shareholder | 184,501 | $22.57 | Sell | $4,164,187.57 | |
Feb. 20, 2024 | Director | 169,539 | $22.72 | Sell | $3,851,926.08 | |
Feb. 16, 2024 | Major Shareholder | 162,707 | $23.14 | Sell | $3,765,039.98 | |
Feb. 15, 2024 | Director | 177,906 | $23.89 | Sell | $4,250,174.34 | |
Feb. 12, 2024 | Insider | 5,493 | $25.07 | Sell | $137,709.51 | |
Jan. 26, 2024 | Insider | 100 | $25.00 | Sell | $2,500.00 | |
Jan. 26, 2024 | SVP | 13,000 | $24.34 | Sell | $316,420.00 | |
Jan. 9, 2024 | Director | 1,714,285 | $17.50 | Buy | $29,999,987.50 |
Insiders are both buying and selling Dyne Therapeutics Inc stock.
The insider traders at Dyne Therapeutics Inc are: Franklin Resources Inc, Richard William Scalzo, Susanna Gatti High, Oxana Beskrovnaya, Jason P Rhodes, Joshua T Brumm, Dirk Kersten, Venture Fund Xi L.P. Atlas, Robert C Flexon, Wildon Farwell, Jonathan Mcneill, Robert C. Flexon, Clint Freeland, Johanna Friedl-Naderer, Mario E Alonso, Martin W Daley, Jeffrey Scott Stein, Patrick Wood III, Paul M Barbas, Hilary E Ackermann, Henry D Jones, Ecp Controlco, Llc, Daniel P Thompson, Carlo Incerti, and John Cox
The most active insider trader at Dyne Therapeutics Inc is Franklin Resources Inc with 100 trades.
Franklin Resources Inc has sold the most Dyne Therapeutics Inc stock with a total value of $642,516,995.93.
Dirk Kersten has bought the most Dyne Therapeutics Inc stock with a total value of $59,999,975.00.
The most recent insider trade for Dyne Therapeutics Inc was on March 13, 2025.
The single biggest insider buy for Dyne Therapeutics Inc was from Dirk Kersten with a total value of $29,999,987.50 on Jan. 9, 2024.
The single biggest insider sell for Dyne Therapeutics Inc was from Ecp Controlco, Llc with a total value of $61,897,500.00 on Jan. 9, 2018.